Business Description
Vitrafy Life Sciences Ltd
ISIN : AU0000361297
Description
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution, to retain the quality of cryopreserved biomaterials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 79.94 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 67.86 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 48.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.68 | |||||
| 9-Day RSI | 47.17 | |||||
| 14-Day RSI | 43.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 47.98 | |||||
| Quick Ratio | 47.98 | |||||
| Cash Ratio | 44.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.24 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -28835.14 | |||||
| Net Margin % | -28175.68 | |||||
| FCF Margin % | -18389.19 | |||||
| ROE % | -26.07 | |||||
| ROA % | -25.22 | |||||
| ROIC % | -360.56 | |||||
| ROC (Joel Greenblatt) % | 0.94 | |||||
| ROCE % | 0.02 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1720 | |||||
| PB Ratio | 2.75 | |||||
| Price-to-Tangible-Book | 2.73 | |||||
| EV-to-EBIT | 10332.43 | |||||
| EV-to-EBITDA | 10332.43 | |||||
| EV-to-Revenue | 1954.78 | |||||
| EV-to-FCF | -10.63 | |||||
| Price-to-Net-Current-Asset-Value | 2.82 | |||||
| Price-to-Net-Cash | 3.02 | |||||
| Earnings Yield (Greenblatt) % | 0.01 | |||||
| FCF Yield % | -6.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vitrafy Life Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.037 | ||
| EPS (TTM) (A$) | -0.163 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 43.82 | ||
| 14-Day ATR (A$) | 0.057617 | ||
| 20-Day SMA (A$) | 1.7265 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (A$) | 1.65 - 2.1 | ||
| Shares Outstanding (Mil) | 63.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vitrafy Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vitrafy Life Sciences Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vitrafy Life Sciences Ltd Frequently Asked Questions
What is Vitrafy Life Sciences Ltd(ASX:VFY)'s stock price today?
The current price of ASX:VFY is A$1.72. The 52 week high of ASX:VFY is A$2.10 and 52 week low is A$1.65.
When is next earnings date of Vitrafy Life Sciences Ltd(ASX:VFY)?
The next earnings date of Vitrafy Life Sciences Ltd(ASX:VFY) is .
Does Vitrafy Life Sciences Ltd(ASX:VFY) pay dividends? If so, how much?
Vitrafy Life Sciences Ltd(ASX:VFY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers